AR and posterior cortical atrophy: Small cell neuroendocrine prostate cancer (SCNC) is an aggressive subtype of prostate cancer (PCa) defined by characteristic features such as a high nuclear to cytoplasmic ratio and indistinct cell borders [1], low or no expression of the androgen receptor (AR) [2], and poor prognosis [3].